This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Ren Liu
Principal Scientist at Merck


Ren Liu, PhD, is a Principal Scientist at Merck & Co., Inc. in Kenilworth, New Jersey, USA. He currently leads the Cell Engineering group in Merck’s BioProcess department and serves as the CMC lead of an early stage Oncology program. Before joining Merck, Dr. Liu worked at VasGene Therapeutics, responsible for the early development of several therapeutic biologics. Dr. Liu received his PhD in Biochemistry from City of Hope Graduate School of Biological Sciences and his BS from the University of Science and Technology of China.

Agenda Sessions

  • Mitigation of Antibody Sulfation by CHO Host Selection and Inhibitor Supplementation

  • PANEL: Utilizing an Assortment of Cell Line Types for Complex Biopharmaceutical Production